日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Preclinical Characterization of Efficacy and Pharmacodynamic Properties of Finotonlimab, a Humanized Anti-PD-1 Monoclonal Antibody.

人源化抗PD-1单克隆抗体Finotonlimab的临床前疗效和药效学特性表征

Yao Yunqi, Yang Xiaoning, Li Jing, Guo Erhong, Wang Huiyu, Sun Chunyun, Hong Zhangyong, Zhang Xiao, Jia Jilei, Wang Rui, Ma Juan, Dai Yaqi, Deng Mingjing, Yu Chulin, Sun Lingling, Xie Liangzhi

Exosomal PDL1 Suppresses the Anticancer Activity of CD8+ T Cells in Hepatocellular Carcinoma

外泌体PDL1抑制肝细胞癌中CD8+T细胞的抗癌活性

Qi Hu, Shuai Chen, Rilin Deng, Hongyu Deng, Mingjing Peng, Xiaohong Wang, Shun Deng, Jinfeng Wang, Biaoming Xu, Yan Xu, Haizhen Zhu, Jinhai Zheng, Man Xia, Chaohui Zuo

Exosomal PD‑L1 promotes the formation of an immunosuppressive microenvironment in gastric diffuse large B‑cell lymphoma

外泌体 PD-L1 促进胃弥漫大 B 细胞淋巴瘤中免疫抑制微环境的形成

Hui Zeng, Jinfeng Wang, Biaoming Xu, Hongyu Deng, Mingjing Peng, Rilin Deng, Song Shang, Qi Hu, Junjun Li, Jinguan Lin, Haizhen Zhu, Yajun Li, Chaohui Zuo